GSK248233A
GSK248233A is a dual inhibitor of Fluc and VEGFR2 with IC50 of 1.03 μM and 2 nM, respectively. GSK248233A also shows activity against the AGC family. GSK248233A acts as a protein kinase inhibitor across ATP-dependent and -independent luciferases with potential implications for Fluc reporter assays.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 850665-21-3
- Formule: C25H24N8O3
- Masse moléculaire:484.51
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform VEGFR
More
Activité biologique
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Sf9 | IC50 |
2 nM
Compound: 6h
|
Inhibition of human ROCK1 in Sf9 cells
Inhibition of human ROCK1 in Sf9 cells
|
[PMID: 17201404] |
Chemical Information
-
CAS No. 850665-21-3
-
Masse moléculaire 484.51
-
Formule C25H24N8O3
-
SMILES
O=C(C1=CC=C(N(C)C)C=C1)NC2=CC(OC3=CC(N(CC)C(C4=NON=C4N)=N5)=C5C=N3)=CC=C2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)